Cantor Fitzgerald Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsOct 31 07:34 ET · Ratings

Baird Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsOct 24 11:31 ET · Ratings

Optimism for Taysha Gene Therapies: Promising Preclinical Data and Upcoming Catalysts Drive Buy Rating

TipRanksOct 24 10:48 ET · Ratings

CCORF Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsOct 23 08:31 ET · Ratings

Taysha Gene Therapies to Present Biodistribution Data From an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

GlobeNewswireOct 22 08:00 ET

Taysha Gene Therapies (TSHA) Upgraded to Strong Buy: Here's Why

Yahoo FinanceOct 14 12:00 ET